Company Filing History:
1 out of 33 
1 out of 509 
Years Active: 2025
Title: Innovations in Cancer Treatment by Marka Crittenden
Introduction
Marka Crittenden is a notable inventor based in Portland, Oregon, recognized for his contributions to cancer therapeutics. His innovative approach focuses on enhancing the immune response in cancer treatment, which has the potential to improve patient outcomes significantly.
Latest Patents
Crittenden holds a patent for "Cancer therapeutic compositions and methods targeting DNAse1L3." This patent outlines methods for treating cancer by administering an effective amount of an inhibitor of DNAse1L3 alongside radiation therapy. The methods aim to enhance or induce the response of tumor-associated immune cells, such as dendritic cells or macrophages, thereby improving the effectiveness of cancer treatments.
Career Highlights
Throughout his career, Marka Crittenden has worked with prominent organizations, including Providence Health & Services - Oregon and Oregon Health & Science University. His work in these institutions has allowed him to collaborate with leading experts in the field of cancer research and treatment.
Collaborations
Crittenden has collaborated with notable colleagues, including Michael Gough and Tiffany Blair, contributing to advancements in cancer therapies and research.
Conclusion
Marka Crittenden's innovative work in cancer treatment exemplifies the potential of targeted therapies to enhance immune responses against tumors. His contributions are paving the way for more effective cancer treatments in the future.